Elena Ardini

Title: Innovations of Elena Ardini in Biochemical Screening

Introduction

Elena Ardini is a notable inventor based in Milan, Italy. She has made significant contributions to the field of biochemical screening, particularly in drug-lead discovery. Her innovative approach emphasizes the importance of quality in functional assays over quantity.

Latest Patents

Elena Ardini holds a patent for "Fluorine NMR spectroscopy for biochemical screening." This method focuses on High-Throughput Screening (HTS) of large compound libraries, which is essential for discovering potential drug leads. The technique extends a biochemical NMR method originally proposed by Percival and Withers, allowing for the screening of Ser/Thr kinases. The method requires the presence of a CF moiety on the substrate and utilizes F NMR spectroscopy to detect both the starting and enzymatically modified substrates. Experiments can be conducted in real-time or in an endpoint assay format, using protein and substrate concentrations comparable to those used by other HTS techniques. The application of this technique to the phosphorylation of a substrate by the protein Ser/Thr kinase AKT1 showcases its effectiveness.

Career Highlights

Elena Ardini is currently employed at Pfizer Italia S.r.l., where she continues to advance her research in biochemical screening. Her work has been instrumental in enhancing the methodologies used in drug discovery.

Collaborations

Elena has collaborated with notable colleagues, including Claudio Dalvit and Maria Magdalena Flocco. Their combined expertise has contributed to the success of her innovative projects.

Conclusion

Elena Ardini's contributions to biochemical screening through her patented methods highlight her role as a leading inventor in the field. Her work not only advances scientific understanding but also paves the way for future innovations in drug discovery.